Clinical feasibility and treatment outcomes with unselected autologous tumour-infiltrating lymphocyte (TIL) therapy in patients with advanced cutaneous melanoma
Authors
Hawkins, Robert EJiang, Y.
Lorigan, Paul C
Thistlethwaite, Fiona C
Pillai, Manon
Thomas, M.
Kirillova, N.
Bridgeman, J. S.
Kueberuwa, G.
Guest, R. D.
Roberts, Z. J.
Affiliation
Instil Bio, Inc., Tarzana, CA;Issue Date
2021